82 HarkinA.ConnorT
Commonly analyzed GLP-1 therapeutics include semaglutide, liraglutide, exenatide, dulaglutide, and other GLP-1 receptor agonists
Tuan-Mahmood T-M, McCrudden MTC, Torrisi BM, McAlister E, Garland MJ, Singh TRR, et al
But some people taking the medication do, in fact, experience them because of the rapid weight loss from the drug
Goal: Support tissue repair, reduce inflammation, and accelerate recovery from musculoskeletal injuries [1] [3]
While originally developed for diabetes, both Semaglutide and Tirzepatide have separate FDA approvals for chronic weight management in adults with obesity or weight-related health issues